Sanofi and GlaxoSmithKline announced that the covid-19 vaccine plan was postponed.

IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives

In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow

Yilite Technology Completes A+ Round Financing of CNY 100 Million

Yilite Technology has secured over CNY 100 million in two rounds of financing within the year.

CRO Enterprise ICE Bioscience Completes B++ Round of Financing

ICE Bioscience is dedicated to new drug targets and drug discovery.

Big Vision Medical Secures Financing of USD 30 Million in the Ophthalmology Field

Big Vision Medical Accelerates Innovation and Global Expansion in Ophthalmology.

AI Medical Company Subtle Medical Secures Nearly Ten Mn USD in Series B+ Financing Round

Subtle Medical is expected to exceed a billion CNY in global revenue in 2024.